Malaysia
kidney function test market is anticipated to grow significantly in the projected
period of 2024-2028. The increasing prevalence of chronic kidney diseases in
Malaysia is one of the key factors driving the growth of the Malaysia kidney
function test market. Chronic kidney diseases are a common health problem in
Malaysia, among the adult population. The rising incidence of chronic kidney
diseases has increased the demand for kidney function tests in the country. Another
factor driving the market growth is the increasing awareness among the
Malaysian population about the importance of early detection and management of
kidney diseases. The primary cause of tuberculosis, which is most frequently
caused by respiratory infections, is the type of bacteria. When an infected
person cough, sneeze, or spit, it spreads via the air. It is possible to prevent
and treat tuberculosis. A person if infected but not yet ill cannot spread the
disease. Antibiotics are typically used to treat TB disease, which can be
lethal if left untreated. The government and private healthcare organizations
are taking initiatives to promote the early detection and management of chronic
kidney diseases, which is further boosting the demand for kidney function
tests.
Another key driver of the Malaysia Kidney
Function Test market is the rising prevalence of diabetes in the country.
Unhealthy diets, sedentary lifestyles, obesity, and genetic predisposition are
some of the factors contributing to the high diabetes prevalence in Malaysia. Diabetes
raises the likelihood of both failure and death as well as death and relapse,
in tuberculosis patients. There is the necessity of paying more attention to
diabetes-related tuberculosis treatment, which may include testing for diabetes
suspicion, better glucose management, and increased clinical and therapeutic
monitoring leading to the growth of Malaysia kidney function test market. According
to the National Health and Morbidity Survey 2019 (NHMS 2019), 49% of Malaysians
with diabetes had never undergone testing or received a diagnosis. Also,
the prevalence of kidney disorders is more among the geriatric population, and
rising population of aged people leads to the huge demand for the Malaysia kidney
function test market. As individuals age, the risk of developing
chronic kidney disease increases. Hence, as a person’s age increases, regular
monitoring of their kidney function gets more important. This has led to a
surge in demand for kidney function tests, which has consequently led to an
increase in the number of diagnostic laboratories and medical facilities
offering these tests. According to Economic and Social Commission for Asia
and the Pacific (ESCAP), as of 2023, the population aged 60+ is 4,043 which is
almost about 11.8% of the total population. Malaysia will be an "aged
society" by 2044, when 14% of the population is predicted to be over 65
and by 2056 Malaysia will be a "super-aged society" with more than
20% of the population being over 65.
Rising Prevalence of Kidney Disorders is Booming the Malaysia
Kidney Function Test Market
Kidney
disorders are becoming increasingly common in Malaysia, with factors such as a
sedentary lifestyle, unhealthy diet, and aging population contributing to the
rising incidence of kidney disease. As a result, the demand for kidney function
tests is expected to surge in the coming years, leading to a growth in the
Malaysia kidney function test market. Conditions that harm kidneys and lessen
their capacity to keep people healthy by filtering waste from blood are
included in chronic kidney disease. Waste can accumulate at high levels in the blood
and make a person feel ill if kidney health worsens. The risk of developing
heart and blood vessel disease is increased by kidney disease. These issues may
develop gradually over a long period of time. Often, chronic kidney disease can
be prevented from getting worse by early detection and treatment leading to the
growth of Malaysia kidney function test market. As kidney disease worsens,
kidney failure may develop, which calls for dialysis or a kidney transplant to
stay alive. One of the key factors
driving the growth of the Malaysia kidney function test market is the high
prevalence of diabetes and hypertension in the country. These two conditions
are leading causes of kidney disease and can go undetected for years, leading
to irreversible damage to the kidneys. Regular kidney function tests can help
detect early signs of kidney disease, allowing for prompt intervention and
management. In addition, the aging population in Malaysia is contributing to
the rising incidence of kidney disease. As people age, the risk of developing
kidney disease increases, and regular kidney function tests become more
important. According to the
Department of Statistics Malaysia (DoSM), the proportion of
Malaysia's population over the age of 65 increased as well, from 5% in 2010 to 6.8%
in 2020 and by 2050, more than 15% of Malaysia's population would be over the
age of 65. The growing awareness about the importance of
kidney function tests and the availability of advanced diagnostic technologies
are driving the Malaysia Kidney Function Test Market.
Download Free Sample Report
Rising Technological Advancements Leads to Rising Demand
for Kidney Function Test.
One of the most common chronic illnesses is kidney
disease, which frequently worsens diabetes, heart disease, and obesity.
Innovative technology and recent developments in biomedical research have made
it possible to study kidney disease on many different platforms and in relation
to human populations, leading to the expansion of the
Malaysia kidney function test market. The
rapid pace of technological advancements in healthcare is driving the growth of
the Malaysia kidney function test market. According to the International
Trade Administration, The Ministry of Health (MOH) has received $7.7 billion
from the government for operating and development costs.
Kidney function tests are a crucial aspect of
diagnosing and monitoring kidney diseases, and technological advancements have
led to the development of more accurate and efficient tests. The
Malaysia kidney function test market is
expected to experience significant growth in the coming years as a result of
these advancements. Technological advancements have led to the development of
more accurate and efficient kidney function tests. For example, the
introduction of automated immunoassay systems has significantly improved the
accuracy and speed of testing. These systems use advanced technologies such as
chemiluminescence and fluorescence to measure the levels of various markers in
the blood, which can provide a more accurate diagnosis of kidney diseases,
hence augmenting the growth of the Malaysia kidney function test market. In addition to improved accuracy, technological
advancements have led to the development of point-of-care testing (POCT) devices,
which can provide results in minutes. These devices are particularly useful in
remote areas where access to laboratory facilities is limited. POCT devices are
portable, easy to use, and require only a small amount of blood, making them
ideal for use in resource-limited settings. The adoption of electronic health
records (EHRs) has contributed to the growth of the Malaysia kidney function
test market. EHRs allow healthcare providers to access patient information
quickly and easily, which can improve the accuracy and speed of diagnosis and
treatment. EHRs allow for the integration of laboratory results, which can provide
a more comprehensive view of a patient's health status, which is expected to
grow the Malaysia kidney function test market. Another factor driving the growth of the Malaysia kidney function test
market is the increasing focus on preventive healthcare. Preventive healthcare
involves early diagnosis and intervention to prevent the progression of
diseases. Kidney function tests are an essential component of preventive healthcare,
as they can detect early signs of kidney disease and allow for timely intervention.
According to a study published in the Journal of the American Medical
Association (JAMA), the incidence of chronic kidney disease (CKD) in Malaysia
is approximately 8.8%, which is higher than the global average of 7.2%.
Recent Development
- In October 2019, Siemens
Healthineers launched a partnership with Healthy.io. This partnership lets the patients test
their urine using smartphones by scanning a dipstick and therefore sending it
to the doctors for further examination. The second-most common diagnostic
test worldwide is urine testing. Patients with chronic renal illness must
undergo routine testing to evaluate their kidney function and look for any
indications of diabetes.
Market Segmentation
Malaysia kidney function
test market is segmented based on type, component, end user, and company. Based on type, Malaysia
kidney function test market is divided into urine tests and blood tests.
Based on component, Malaysia kidney function test market is categorized into dipsticks,
reagents, kits & assays, and others. Based on end user, Malaysia kidney
function test market is categorized into hospitals & clinics, diagnostic
laboratories and others. Based on region, the Malaysia kidney function test
market is segmented into the east Malaysia and west Malaysia.
Company Profiles
Siemens Healthcare
Private Limited, Pfizer Inc, Abbott Laboratories, Inc, Danaher Corporation, bioMérieux
Malaysia Sdn Bhd, and Astrazeneca Sdn. Bhd. are some of the key players of Malaysia
kidney function test market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume in tons and CAGR for
2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue forecast,
volume forecasting, Company shares, competitive landscape, growth factors,
and trends
|
|
Segments covered
|
Type
Component
End User
|
|
Country scope
|
The East
Malaysia and The West Malaysia
|
|
Key companies profiled
|
Siemens
Healthcare Private Limited, Pfizer Inc, Abbott Laboratories, Inc, Danaher
Corporation, bioMérieux Malaysia Sdn Bhd, Astrazeneca Sdn. Bhd.
|
|
Customization scope
|
10% free report customization with purchase.
Addition or alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized
purchase options to meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF
and Excel through Email (We can also provide the editable version of the
report in PPT/Word format on special request)
|
Report Scope:
In this report, the Malaysia kidney function test market has been segmented into the following categories, in addition
to the industry trends, which have also been detailed below:
- Malaysia Kidney
Function Test Market, By Type:
- Malaysia Kidney
Function Test Market, By Component:
- Dipsticks
- Reagents
- Kits & Assays
- Others
- Malaysia Kidney Function Test Market, By End User:
- Hospitals &
Clinics
- Diagnostic
Laboratories
- Others
- Malaysia Kidney
Function Test Market, By Region:
- The
East Malaysia
- The
West Malaysia
Competitive landscape
Company Profiles: Detailed analysis of the major companies in Malaysia
kidney function test market.
Available Customizations:
With the given market data, TechSci Research offers customizations
according to a company’s specific needs. The following customization options are
available for the report:
Company
Information
- Detailed analysis and profiling of additional market players
(up to five).
Malaysia Kidney Function Test Market is
an upcoming report to be released soon. If you wish an early delivery of this report
or want to confirm the date of release, please contact us at [email protected]